CI
US EQUITY
Health Care
Health Care Services
CIK: 1739940
Cigna (CI) Quant Factor Diagnostic & Fair Value Model
Cigna (Ticker: CI) is listed in the Health Care sector (Health Care Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$306.95
-2.83%
Latest Close (2026-10-23)
Market Cap: $410.84M
P/E Ratio: 12.2
Momentum Strength
3M / 12M
+5.47%
1M: +15.61%
12M: -0.30%
Quality (ROE)
Point-in-Time
+15.47%
Trailing Return on Equity
Technical Trend
RSI 14
76.5
SMA50: $281.76
SMA200: $281.08
Valuation Multiplier
Trailing
12.2
Deep Value (Under 15x P/E)
📊
Valuation & Multi-Factor Diagnostic
Deep Value (Under 15x P/E)
CI trades at an attractive earnings multiple of 12.2x, significantly lower than the broader S&P 500 average.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 5/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1739940 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-07-30 | $71.67B | $1.66B | $710.00M | $6.29 |
| 10-Q | 2025-12-31 | 2026-07-30 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-07-30 | $67.18B | $1.53B | $34.00M | $5.71 |
| 10-Q | 2026-03-31 | 2026-04-30 | $68.49B | $1.65B | $1.13B | $6.26 |
| 10-Q | 2025-03-31 | 2026-04-30 | $65.50B | $1.32B | $1.92B | $4.85 |
| 10-K | 2025-12-31 | 2026-02-26 | $274.90B | $5.96B | $9.60B | $22.18 |
| 10-K | 2024-12-31 | 2026-02-26 | $247.12B | $3.43B | $10.36B | $12.12 |
| 10-K | 2023-12-31 | 2026-02-26 | $195.26B | $5.16B | $11.81B | $17.39 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Cigna (CI) valuation multiples, momentum factors, and point-in-time filing conventions.
How should CI's current valuation multiple be interpreted? ↓
CI trades at a trailing P/E of 12.2x within the Health Care sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are CI's key momentum and technical factor indicators? ↓
As of the latest close, CI shows a 1-month return of +15.61%, 3-month return of +5.47%, and 12-month return of -0.30%, with a 14-day RSI of 76.5. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for CI? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can CI be incorporated into systematic factor models? ↓
CI can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.